EverSource Wealth Advisors’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Buy |
10,118
+5,173
| +105% | +$556K | 0.05% | 256 |
|
2025
Q1 | $499K | Buy |
4,945
+2,095
| +74% | +$211K | 0.03% | 383 |
|
2024
Q4 | $255K | Buy |
2,850
+421
| +17% | +$37.6K | 0.01% | 560 |
|
2024
Q3 | $204K | Buy |
2,429
+193
| +9% | +$16.2K | 0.01% | 548 |
|
2024
Q2 | $165K | Sell |
2,236
-3
| -0.1% | -$222 | 0.01% | 624 |
|
2024
Q1 | $161K | Buy |
2,239
+118
| +6% | +$8.48K | 0.01% | 559 |
|
2023
Q4 | $123K | Buy |
2,121
+185
| +10% | +$10.7K | 0.01% | 575 |
|
2023
Q3 | $102K | Sell |
1,936
-71
| -4% | -$3.75K | 0.01% | 561 |
|
2023
Q2 | $109K | Buy |
2,007
+47
| +2% | +$2.54K | 0.01% | 553 |
|
2023
Q1 | $98.1K | Sell |
1,960
-269
| -12% | -$13.5K | 0.01% | 549 |
|
2022
Q4 | $103K | Sell |
2,229
-713
| -24% | -$33K | 0.02% | 495 |
|
2022
Q3 | $114K | Sell |
2,942
-1,127
| -28% | -$43.7K | 0.03% | 397 |
|
2022
Q2 | $151K | Sell |
4,069
-1,113
| -21% | -$41.3K | 0.04% | 295 |
|
2022
Q1 | $230K | Buy |
5,182
+881
| +20% | +$39.1K | 0.06% | 240 |
|
2021
Q4 | $184K | Buy |
+4,301
| New | +$184K | 0.05% | 231 |
|